CLINICAL_TRIALS
trial_result
· 2011-06-23
Clinical Trial Update: Phase IIA Study in Patients With Schizophrenia [Phase 2]
Summary
A Phase IIa study in schizophrenia conducted by AstraZeneca has completed, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2011-06-23